Key terms

About STIM

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 1998 and is headquartered in Malvern, PA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest STIM news

Mar 28 4:27pm ET Neuronetics Inc Shrinks Board Following Strategy Review by TipRanks Mar 26 7:16am ET Buy Rating for Neuronetics Amid FDA Clearance and Expanding Adolescent MDD Market by TipRanks Mar 25 8:51am ET NeuroStar Advanced Therapy receives FDA clearance by TipRanks Mar 07 8:23am ET Neuronetics announces 5-year exclusive partnership with TCN by TipRanks Mar 06 4:14pm ET Neuronetics Inc Boosts Executive Compensation for Top Leaders by TipRanks Mar 06 7:37am ET Piper Sandler Sticks to Their Buy Rating for Neuronetics (STIM) by TipRanks Mar 06 7:22am ET Neuronetics price target raised to $8 from $7 at Piper Sandler by TipRanks Mar 06 12:30am ET Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Marinus (MRNS) and Gritstone Oncology (GRTS) by TipRanks Mar 05 7:42am ET Neuronetics Inc Shares New Investor Insights Online by TipRanks Mar 05 7:41am ET Neuronetics reports Q4 EPS (19c), consensus (26c) by TipRanks Feb 12 8:34am ET Neuronetics announces enhancements to TrakStar Patient Data Management System by TipRanks Feb 06 8:29am ET Neuronetics TMS patient access expands through Lucet Health policy update by TipRanks Jan 09 7:53am ET Neuronetics Stock Receives Buy Rating from Canaccord Genuity Amid Strong Q4 Performance and Positive Outlook by TipRanks Jan 08 8:48am ET Neuronetics sees 2023 revenue over $71M, consensus $70.77M. by TipRanks Jan 08 8:47am ET Neuronetics sees Q4 revenue over $20M, consensus $19.76M by TipRanks

No recent news articles are available for STIM

No recent press releases are available for STIM

STIM Financials

1-year income & revenue

Key terms

STIM Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

STIM Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’